Waser B, Blank A, Karamitopoulou E, Perren A, Reubi JC
As someone who has experienced the benefits of B12 shots firsthand, I understand how important it is to know just how long these effects can last
A lower dose does not necessarily mean lower risk
As previously noted, even the lowest effective 4mg aw dose provided compelling health benefits It will be compelling to see how triple-agonist therapy is tolerated in the long term especially given that single and dual incretin-based therapies show substantial discontinuation rates in real-world settings, in some cohorts approaching 70%
In the 6 mg group, 49.5% reached this threshold
One thing that I reflect on and consider is that even some of the early anti-amyloid therapies that ultimately failed to slow disease progression did show some change in the Alzheimers biomarkers, she told Being Patient